These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Experimental and clinical research on the effect of keyouling on condyloma acuminatum and adjustment of cellular immunity function]. Jiang Y; Wan K; Wang C; Wang P; Chen Y; Zeng X; Zhang S Zhonghua Nan Ke Xue; 2004 Jan; 10(1):67-70. PubMed ID: 14979213 [TBL] [Abstract][Full Text] [Related]
8. Natural killer cell activity in oral cancer patients: II. Correlation of in-vitro modulation by leukocyte interferon with circulating interferon and interferon induction by K 562 cells. Gore MM; Jamkar AV; Kedarnath N; Banerjea AC; Mehta MJ; Ghosh SN Indian J Cancer; 1983 Mar; 20(1A):54-8. PubMed ID: 6873993 [No Abstract] [Full Text] [Related]
9. Natural killer cell activity in patients with multiple sclerosis given alpha interferon. Rice GP; Casali P; Merigan TC; Oldstone MB Ann Neurol; 1983 Sep; 14(3):333-8. PubMed ID: 6638954 [TBL] [Abstract][Full Text] [Related]
10. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity. Edwards BS; Hawkins MJ; Borden EC Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292 [TBL] [Abstract][Full Text] [Related]
11. Interferon enhanced natural killer function in Hodgkin's disease. Levy S; Reins F; Aleksijevic A; Giron C; Oberling F; Mayer S; Lang JM Nouv Rev Fr Hematol (1978); 1986; 28(5):323-5. PubMed ID: 3808943 [TBL] [Abstract][Full Text] [Related]
12. [Effects of non-immune interferons and interleukin-2 on the activity of natural killer cells in patients with hairy cell leukemia]. Schippa M; Fizzotti M; Cini L; Senatore M Medicina (Firenze); 1988; 8(2):163-6. PubMed ID: 3265755 [No Abstract] [Full Text] [Related]
13. Modulation of natural killing activity by lymphoblastoid interferon in cancer patients. Koren HS; Brandt CP; Tso CY; Laszlo J J Biol Response Mod; 1983; 2(2):151-65. PubMed ID: 6644332 [TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal recombinant alpha-interferon for "salvage" immunotherapy in stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. Berek JS; Hacker NF; Lichtenstein A; Jung T; Spina C; Knox RM; Brady J; Greene T; Ettinger LM; Lagasse LD Cancer Res; 1985 Sep; 45(9):4447-53. PubMed ID: 4028027 [TBL] [Abstract][Full Text] [Related]
15. Natural killer cells and interferon responses in patients with systemic lupus erythematosus. Tsokos GC; Rook AH; Djeu JY; Balow JE Clin Exp Immunol; 1982 Nov; 50(2):239-45. PubMed ID: 6817954 [TBL] [Abstract][Full Text] [Related]
16. [The use of leukocyte interferon in the combined therapy of condylomata acuminata of the genitals]. Sycheva LG; Kubanova AA Vestn Dermatol Venerol; 1990; (1):58-60. PubMed ID: 2327173 [TBL] [Abstract][Full Text] [Related]
17. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B. Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911 [TBL] [Abstract][Full Text] [Related]
18. Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon. Lotzová E; Savary CA; Quesada JR; Gutterman JU; Hersh EM J Natl Cancer Inst; 1983 Nov; 71(5):903-10. PubMed ID: 6580490 [TBL] [Abstract][Full Text] [Related]
19. The anti-condyloma acuminatum effects of interferon-inducible protein 10 in vitro. Li H; Yi T; Zhao S; Chen P; Cheng C; Wei Y; Zhao X Int J Dermatol; 2009 Feb; 48(2):136-41. PubMed ID: 19200187 [TBL] [Abstract][Full Text] [Related]
20. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons. Brunda MJ; Rosenbaum D Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]